Deutsche Bank
NXTC icon

Deutsche Bank’s NextCure NXTC Stock Holding History

Deutsche Bank’s Portfolio NXTC Stock Details NXTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-593
Closed -$57K – 4594
2021
Q2 		$57K Sell
593
-4,106
-87% -$420K ﹤0.01% 4282
2021
Q1 		$565K Sell
4,699
-493
-9% -$71.4K ﹤0.01% 3019
2020
Q4 		$678K Sell
5,192
-40,717
-89% -$5.26M ﹤0.01% 2709
2020
Q3 		$4.85M Buy
45,909
+45,228
+6,641% +$5.56M ﹤0.01% 1277
2020
Q2 		$175K Buy
681
+252
+59% +$95.9K ﹤0.01% 3204
2020
Q1 		$191K Sell
429
-2
-0.5% -$1.07K ﹤0.01% 2972
2019
Q4 		$290K Buy
431
+360
+507% +$181K ﹤0.01% 3017
2019
Q3 		$25K Sell
71
-111
-61% -$36.1K ﹤0.01% 4242
2019
Q2 		$32K Buy
+182
New +$37.8K ﹤0.01% 4681

Other funds holding NXTC

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Deutsche Bank's NXTC Position: Q3 2021 in Review

Deutsche Bank sold out of NextCure (NXTC) in Q3 2021, closing a stake of 593 shares — an estimated $57K sold.

Deutsche Bank first reported a position in NXTC in Q2 2019 and held it in 9 quarters. The position peaked at $4.85M in Q3 2020. 71 funds tracked by Wall St. Rank hold NXTC as of Q3 2021.

  • Deutsche Bank reported no remaining NextCure position as of Q3 2021 after selling out during the quarter.
  • Deutsche Bank sold 593 NextCure shares in Q3 2021, an estimated $57K.
  • Deutsche Bank first reported a position in NextCure in Q2 2019 and held it in 9 quarters.
  • Deutsche Bank's NextCure position peaked at $4.85M in Q3 2020.
  • 71 funds tracked by Wall St. Rank held NextCure as of Q3 2021.

Based on Deutsche Bank's 13F filing for Q3 2021, filed 4 Nov 2021.